Anti-obesity effects of Lysimachia foenum-graecum characterized by decreased adipogenesis and regulated lipid metabolism

[1]  R. Lin,et al.  Two new triterpenes from Lysimachia foenum-graecum , 2010, Journal of Asian natural products research.

[2]  K. Park,et al.  Further understanding of fat biology: Lessons from a fat fly , 2010, Experimental & Molecular Medicine.

[3]  M. Lane,et al.  Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. , 2009, American journal of physiology. Endocrinology and metabolism.

[4]  F. Thiesen,et al.  Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity , 2009, Pharmacological reports : PR.

[5]  Yuzhi Zhang,et al.  AICAR activates the pluripotency transcriptional network in embryonic stem cells and induces KLF4 and KLF2 expression in fibroblasts , 2009, BMC pharmacology.

[6]  R. Lin,et al.  Two triterpenes from Lysimachia foenum-graecum , 2009, Journal of Asian natural products research.

[7]  Y. Surh,et al.  Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. , 2009, Journal of agricultural and food chemistry.

[8]  T. Park,et al.  Ilex paraguariensis extract ameliorates obesity induced by high-fat diet: potential role of AMPK in the visceral adipose tissue. , 2008, Archives of biochemistry and biophysics.

[9]  Ha Won Kim,et al.  Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose tissue of rats. , 2008, Biological & pharmaceutical bulletin.

[10]  B. Viollet,et al.  Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. , 2007, Diabetes & metabolism.

[11]  M. J. Yoon,et al.  Adiponectin Increases Fatty Acid Oxidation in Skeletal Muscle Cells by Sequential Activation of AMP-Activated Protein Kinase, p38 Mitogen-Activated Protein Kinase, and Peroxisome Proliferator–Activated Receptor α , 2006, Diabetes.

[12]  Mengwei Zang,et al.  Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor–Deficient Mice , 2006, Diabetes.

[13]  D. James,et al.  Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States , 2006, Diabetes.

[14]  D. Hardie,et al.  AMP‐activated protein kinase – development of the energy sensor concept , 2006, The Journal of physiology.

[15]  Min-Seon Kim,et al.  AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. , 2006, Biochemical and biophysical research communications.

[16]  Wei‐Lie Xiao,et al.  Five new triterpene glycosides from Lysimachia foenum-graecum and evaluation of their effect on the arachidonic acid metabolizing enzyme. , 2005, Planta medica.

[17]  P. Gorden,et al.  Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. , 2005, Diabetes.

[18]  Philippe Giral,et al.  Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. , 2004, The Journal of clinical endocrinology and metabolism.

[19]  L. Aronne,et al.  Pharmacological approaches to weight reduction: therapeutic targets. , 2004, The Journal of clinical endocrinology and metabolism.

[20]  X. Ge,et al.  Molecular phylogeny of Lysimachia (Myrsinaceae) based on chloroplast trnL-F and nuclear ribosomal ITS sequences. , 2004, Molecular phylogenetics and evolution.

[21]  Jong Bae Seo,et al.  Activated Liver X Receptors Stimulate Adipocyte Differentiation through Induction of Peroxisome Proliferator-Activated Receptor γ Expression , 2004, Molecular and Cellular Biology.

[22]  D. Hardie,et al.  Management of cellular energy by the AMP‐activated protein kinase system , 2003, FEBS letters.

[23]  Pedro Iglesias,et al.  The role of the novel adipocyte-derived hormone adiponectin in human disease. , 2003, European journal of endocrinology.

[24]  O. Ukkola,et al.  Adiponectin: a link between excess adiposity and associated comorbidities? , 2002, Journal of Molecular Medicine.

[25]  K. Petersen,et al.  Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. , 2002, The Journal of clinical investigation.

[26]  Jiahuai Han,et al.  Stimulation of Glucose Transport by AMP-activated Protein Kinase via Activation of p38 Mitogen-activated Protein Kinase* , 2001, The Journal of Biological Chemistry.

[27]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[28]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[29]  Bruce M. Spiegelman,et al.  Obesity and the Regulation of Energy Balance , 2001, Cell.

[30]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[31]  T. Warner,et al.  Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line , 2000, British journal of pharmacology.

[32]  P. Puigserver,et al.  Transcriptional regulation of adipogenesis. , 2000, Genes & development.

[33]  George A. Bray,et al.  Medicinal strategies in the treatment of obesity , 2000, Nature.

[34]  P. Kopelman.  Obesity as a medical problem , 2000, Nature.

[35]  A. Heck,et al.  Orlistat, a New Lipase Inhibitor for the Management of Obesity , 2000, Pharmacotherapy.

[36]  J. Rey,et al.  Sibutramine: A Serotonin–Norepinephrine Reuptake-Inhibitor for the Treatment of Obesity , 1999, The Annals of pharmacotherapy.

[37]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[38]  H. Morkoç,et al.  On the incorporation of Mg and the role of oxygen, silicon, and hydrogen in GaN prepared by reactive molecular beam epitaxy , 1997 .

[39]  B. Spiegelman,et al.  Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ , 1996, Science.

[40]  B. Spiegelman,et al.  Adipocyte differentiation: a transcriptional regulatory cascade. , 1996, Current opinion in cell biology.

[41]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[42]  B. Spiegelman,et al.  Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.

[43]  B. Spiegelman,et al.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.

[44]  Jianping Li,et al.  Antioxidant activities of extracts and fractions from Lysimachia foenum-graecum Hance. , 2009, Bioresource technology.

[45]  Shailendra Giri,et al.  AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model , 2006, Nutrition & metabolism.

[46]  J. Girard,et al.  Phosphorylation of PPARs: from molecular characterization to physiological relevance. , 2005, Biochimie.

[47]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.

[48]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[49]  D. Hardie,et al.  Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. , 1997, Journal of applied physiology.

[50]  B. Spiegelman,et al.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. , 1994, Cell.